Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Jun-19 4:41 PM View:  | Sundaram Senthil Vel Chief Financial Officer | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 126,886 | $25.50 | $3,235,590.00 | (100%) 126.89K to 0 | < 1% |
| 07-Jun-19 4:44 PM View: | Mott David M Director 10% Owner | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition Duplicate | 6,662,530 | $25.50 | $169,895,008.00 | (100%) 6.66M to 0 | < 1% |
| 07-Jun-19 4:35 PM View: | Hollowood Christopher J Director | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition Duplicate | 13,203,900 | $25.50 | $336,700,000.00 | (100%) 13.2M to 0 | < 1% |
| 07-Jun-19 4:38 PM View: | Ong Tuyen Chief Development Officer | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 80,479 | $25.50 | $2,052,210.00 | (100%) 80.48K to 0 | < 1% |
| 07-Jun-19 4:41 PM View: | Whitcup Scott M Director | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 74,568 | $25.50 | $1,901,480.00 | (100%) 74.57K to 0 | < 1% |
| 11-Jun-19 4:30 PM View: | Syncona Portfolio Ltd 10% Owner | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 13,203,900 | $25.50 | $336,700,000.00 | (100%) 13.2M to 0 | < 1% |
| 07-Jun-19 4:36 PM View: | Lubner David Charles Director | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 29,124 | $25.50 | $742,662.00 | (100%) 29.12K to 0 | < 1% |
| 07-Jun-19 4:39 PM View: | Robinson Gregory Scott Chief Scientific Officer | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 103,182 | $25.50 | $2,631,140.00 | (100%) 103.18K to 0 | < 1% |
| 07-Jun-19 4:43 PM View: | New Enterprise Associates 1... 10% Owner | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 6,662,530 | $25.50 | $169,895,008.00 | (100%) 6.66M to 0 | < 1% |
| 07-Jun-19 4:34 PM View: | Fellows David A Chief Executive Officer Director | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 617,090 | $25.50 | $15,735,800.00 | (100%) 617.09K to 0 | < 1% |
| 07-Jun-19 4:37 PM View: | McArthur James G Director | Nightstar Therapeutics Plc (NITE) | 07-Jun-19 | Disposition | 37,237 | $25.50 | $949,544.00 | (100%) 37.24K to 0 | < 1% |
| 03-Apr-19 9:01 PM View: | Robinson Gregory Scott Chief Scientific Officer | Nightstar Therapeutics Plc (NITE) | 01-Apr-19 | Market Sale | 410 | $25.31 | $10,377.10 | (< 1%) 103.59K to 103.18K | (< 1%) |
| 03-Apr-19 9:00 PM View: | Fellows David A Chief Executive Officer Director | Nightstar Therapeutics Plc (NITE) | 01-Apr-19 | Market Sale | 9,305 | $25.31 | $235,510.00 | (1%) 626.39K to 617.09K | (< 1%) |
| 03-Apr-19 9:02 PM View: | Sundaram Senthil Vel Chief Financial Officer | Nightstar Therapeutics Plc (NITE) | 01-Apr-19 | Market Sale | 391 | $25.31 | $9,896.21 | (< 1%) 127.28K to 126.89K | (< 1%) |
| 03-Apr-19 9:01 PM View: | Ong Tuyen Chief Development Officer | Nightstar Therapeutics Plc (NITE) | 01-Apr-19 | Market Sale | 2,446 | $25.31 | $61,908.30 | (3%) 82.92K to 80.48K | (< 1%) |
| 09-Jan-19 9:12 PM View: | Robinson Gregory Scott Chief Scientific Officer | Nightstar Therapeutics Plc (NITE) | 07-Jan-19 | Private Sale | 425 | $19.98 | $8,491.84 | (< 1%) 104.02K to 103.59K | |
| 09-Jan-19 9:13 PM View: | Sundaram Senthil Vel Chief Financial Officer | Nightstar Therapeutics Plc (NITE) | 07-Jan-19 | Market Sale | 406 | $12.98 | $5,270.20 | (< 1%) 127.68K to 127.28K | (96%) |
| 09-Jan-19 9:10 PM View: | Fellows David A Chief Executive Officer Director | Nightstar Therapeutics Plc (NITE) | 07-Jan-19 | Market Sale | 8,733 | $12.98 | $113,361.00 | (1%) 639.56K to 630.83K | (96%) |
| 09-Jan-19 9:12 PM View: | Ong Tuyen Chief Development Officer | Nightstar Therapeutics Plc (NITE) | 07-Jan-19 | Market Sale | 2,546 | $12.98 | $33,049.10 | (3%) 85.47K to 82.92K | (96%) |
| 07-Jan-19 9:20 PM View: | Ong Tuyen Chief Development Officer | Nightstar Therapeutics Plc (NITE) | 03-Jan-19 | Market Sale (Planned) | 4,070 | $12.00 | $48,840.00 | (50%) 8.14K to 4.07K | (112%) |
| 04-Jan-19 4:29 PM View: | Robinson Gregory Scott Chief Scientific Officer | Nightstar Therapeutics Plc (NITE) | 02-Jan-19 | Market Sale (Planned) | 14,764 | $11.15 | $164,619.00 | (24%) 62.76K to 48.0K | (129%) |
